Abatacept Vs. Placebo in Early Diffuse Cutaneous Systemic Sclerosis-Results of a Phase 2 Investigator Initiated, Double- Blind, Placebo-Controlled, Multicenter, Randomized Controlled Trial Study Khanna, D., Spino, C., Bush, E., Johnson, S., Chung, L., Molitor, J., Steen, V. D., Lafyatis, R., Simms, R. W., Denton, C. P., Kafaja, S., Frech, T. M., Hsu, V., Domsic, R. T., Pope, J. E., Gordon, J. K., Mayes, M. D., Schiopu, E., Young, A., Sandorfi, N., Park, J., Hant, F. N., Bernstein, E. J., Chatterjee, S., Castelino, F. V., Ajam, A., Allanore, Y., Matucci-Cerinic, M., Distler, O., Singer, O., Zhong, H., Fox, D., Furst, D. E. WILEY. 2018

View details for Web of Science ID 000447268902001